Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Viral conjunctivitis therapeutics is undergoing a transitional phase. Currently, there is no drug available for the treatment of viral conjunctivitis. However, the presence of a robust pipeline indicates towards a thriving future.
The global market for viral conjunctivitis pipeline drugs is likely to exhibit a thumping CAGR of 69.60% between 2019 and 2026 and reach an opportunity worth US$462.4 mn by the end of the forecast period. The increasing investments from ophthalmic drug manufacturers for the development of efficient treatment for viral conjunctivitis, coupled with the increasing awareness among people and augmenting expenditure on healthcare, are accelerating the growth rate of this market significantly.
The report details the trend, potential and market size of Viral Conjunctivitis Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Viral Conjunctivitis Drugsmarket, defines the market attractiveness level of Viral Conjunctivitis Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Viral Conjunctivitis Drugs industry, describes the types of Viral Conjunctivitis Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Viral Conjunctivitis Drugs market and the development prospects and opportunities of Viral Conjunctivitis Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Viral Conjunctivitis Drugs market in Chapter 13.
By Player:
Adenovir Pharma
NicOx
Allergan
NanoViricides
NovaBay Pharmaceuticals
Shire
Panoptes Pharma
Novartis
By Type:
FST-100
APD-209
By End-User:
Hospitals
ASCs
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Viral Conjunctivitis Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Viral Conjunctivitis Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Viral Conjunctivitis Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Viral Conjunctivitis Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Viral Conjunctivitis Drugs Market Analysis and Outlook to 2022
-
7.1 Global Viral Conjunctivitis Drugs Consumption (2017-2022)
-
7.2 United States Viral Conjunctivitis Drugs Consumption (2017-2022)
-
7.3 Europe Viral Conjunctivitis Drugs Consumption (2017-2022)
-
7.4 China Viral Conjunctivitis Drugs Consumption (2017-2022)
-
7.5 Japan Viral Conjunctivitis Drugs Consumption (2017-2022)
-
7.6 India Viral Conjunctivitis Drugs Consumption (2017-2022)
-
7.7 South Korea Viral Conjunctivitis Drugs Consumption (2017-2022)
8 Region and Country-wise Viral Conjunctivitis Drugs Market Analysis and Outlook to 2028
-
8.1 Global Viral Conjunctivitis Drugs Consumption Forecast (2022-2028)
-
8.2 United States Viral Conjunctivitis Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Viral Conjunctivitis Drugs Consumption Forecast (2022-2028)
-
8.4 China Viral Conjunctivitis Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Viral Conjunctivitis Drugs Consumption Forecast (2022-2028)
-
8.6 India Viral Conjunctivitis Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Viral Conjunctivitis Drugs Consumption Forecast (2022-2028)
9 Global Viral Conjunctivitis Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Viral Conjunctivitis Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global FST-100 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global APD-209 Consumption and Growth Rate (2017-2022)
-
9.2 Global Viral Conjunctivitis Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global ASCs Consumption and Growth Rate (2017-2022)
10 Global Viral Conjunctivitis Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Viral Conjunctivitis Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global FST-100 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global APD-209 Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Viral Conjunctivitis Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global ASCs Consumption Forecast and Growth Rate (2022-2028)
11 Global Viral Conjunctivitis Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Viral Conjunctivitis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Viral Conjunctivitis Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Viral Conjunctivitis Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Viral Conjunctivitis Drugs Market Competitive Analysis
-
14.1 Adenovir Pharma
-
14.1.1 Adenovir Pharma Company Details
-
14.1.2 Adenovir Pharma Viral Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Adenovir Pharma Viral Conjunctivitis Drugs Product and Service
-
14.2 NicOx
-
14.2.1 NicOx Company Details
-
14.2.2 NicOx Viral Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 NicOx Viral Conjunctivitis Drugs Product and Service
-
14.3 Allergan
-
14.3.1 Allergan Company Details
-
14.3.2 Allergan Viral Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Allergan Viral Conjunctivitis Drugs Product and Service
-
14.4 NanoViricides
-
14.4.1 NanoViricides Company Details
-
14.4.2 NanoViricides Viral Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 NanoViricides Viral Conjunctivitis Drugs Product and Service
-
14.5 NovaBay Pharmaceuticals
-
14.5.1 NovaBay Pharmaceuticals Company Details
-
14.5.2 NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Product and Service
-
14.6 Shire
-
14.6.1 Shire Company Details
-
14.6.2 Shire Viral Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Shire Viral Conjunctivitis Drugs Product and Service
-
14.7 Panoptes Pharma
-
14.7.1 Panoptes Pharma Company Details
-
14.7.2 Panoptes Pharma Viral Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Panoptes Pharma Viral Conjunctivitis Drugs Product and Service
-
14.8 Novartis
-
14.8.1 Novartis Company Details
-
14.8.2 Novartis Viral Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Novartis Viral Conjunctivitis Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Viral Conjunctivitis Drugs
-
Figure Viral Conjunctivitis Drugs Picture
-
Table Global Viral Conjunctivitis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Viral Conjunctivitis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Viral Conjunctivitis Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Viral Conjunctivitis Drugs Consumption by Country (2017-2022)
-
Figure United States Viral Conjunctivitis Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Viral Conjunctivitis Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Viral Conjunctivitis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Viral Conjunctivitis Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Viral Conjunctivitis Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Viral Conjunctivitis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Viral Conjunctivitis Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Viral Conjunctivitis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Viral Conjunctivitis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Viral Conjunctivitis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Viral Conjunctivitis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Viral Conjunctivitis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Viral Conjunctivitis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global FST-100 Consumption and Growth Rate (2017-2022)
-
Figure Global APD-209 Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global ASCs Consumption and Growth Rate (2017-2022)
-
Figure Global FST-100 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global APD-209 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ASCs Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Viral Conjunctivitis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Viral Conjunctivitis Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Adenovir Pharma (Foundation Year, Company Profile and etc.)
-
Table Adenovir Pharma Viral Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Adenovir Pharma Viral Conjunctivitis Drugs Product and Service
-
Table NicOx (Foundation Year, Company Profile and etc.)
-
Table NicOx Viral Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table NicOx Viral Conjunctivitis Drugs Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Viral Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Viral Conjunctivitis Drugs Product and Service
-
Table NanoViricides (Foundation Year, Company Profile and etc.)
-
Table NanoViricides Viral Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table NanoViricides Viral Conjunctivitis Drugs Product and Service
-
Table NovaBay Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Viral Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Viral Conjunctivitis Drugs Product and Service
-
Table Panoptes Pharma (Foundation Year, Company Profile and etc.)
-
Table Panoptes Pharma Viral Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Panoptes Pharma Viral Conjunctivitis Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Viral Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Viral Conjunctivitis Drugs Product and Service
-
